This compound is a fluorinated nucleoside analog intermediate, featuring a uracil base attached to a modified ribose sugar with acetyl protecting groups. It is primarily used in the synthesis of nucleoside analogs for pharmaceutical research and manufacturing.
İçerik kapsamı: Bu sayfadaki bilgiler kimyasal tanımlama ile endüstriyel tedarik, araştırma ve üretim bağlamlarına ilişkindir. Tedavi iddiası, tıbbi tavsiye veya ilaç kullanım talimatı niteliği taşımaz.
Bu bileşiği tedarik ediyor veya sağlıyor musunuz?
Envanterinizi listeleyin veya satın alma talebi gönderin
CAS 10212-13-2
(2R,3R,5R)-5-(4-Amino-2-oxopyrimidin-1(2H)-yl)-2-((benzoyloxy)methyl)-4,4-difluorotetrahydrofuran-3-yl benzoate
Pharmaceutical intermediate for nucleoside analogs
((2R,3R,5R)-3-(Benzoyloxy)-4,4-difluoro-5-((methylsulfonyl)oxy)tetrahydrofuran-2-yl)methyl benzoate
Pharmaceutical intermediate for nucleoside analogs
1-O-Acetyl-3,5-bis (4-Chlorobenzoyl)-2-Deoxy-D-ribose
Pharmaceutical intermediate for nucleoside analogs
9-(2-Deoxy-2-fluoroarabinofuranosyl)guanine
Pharmaceutical intermediate for nucleoside analogs
2'-Deoxy-2'-fluorocytidine
pharmaceutical intermediate
Tert-butyl N-[(2S)-4-chloro-3-oxo-1-phenylbutan-2-yl]carbamate
Pharmaceutical intermediate
1-(cyclopropylcarbonyl)piperazine hydrochloride
pharmaceutical intermediate
2-Fluoro-5-((4-oxo-3,4-dihydrophthalazin-1-yl)methyl)benzonitrile
pharmaceutical intermediate
[(2R,3R,4R,5R)-3-acetyloxy-5-(2,4-dioxopyrimidin-1-yl)-4-fluorooxolan-2-yl]methyl acetate
SGWNQYIJJOVQCM-HJQYOEGKSA-N
CC(=O)OC[C@@H]1[C@H]([C@H]([C@@H](O1)N2C=CC(=O)NC2=O)F)OC(=O)C
—